4.6 Review

CD81-Receptor Associations - Impact for Hepatitis C Virus Entry and Antiviral Therapies

期刊

VIRUSES-BASEL
卷 6, 期 2, 页码 875-892

出版社

MDPI
DOI: 10.3390/v6020875

关键词

antivirals; claudin-1; kinases; liver; transplantation

类别

资金

  1. European Union [ERC-2008-AdG-233130-HEPCENT, Interreg IV FEDER-Hepato-Regio-Net 2012, FP7 HEPAMAB GAN 305600]
  2. Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS) [2012/239, 2013/081, 2013/249]
  3. Direction Generale de l'Offre de Soins [A12027MS]
  4. Inserm
  5. University of Strasbourg
  6. ARC (TheraHCC)
  7. French National Research Agency

向作者/读者索取更多资源

Tetraspanins are integral transmembrane proteins organized in microdomains displaying specific and direct interactions with other tetraspanins and molecular partners. Among them, CD81 has been implicated in a variety of physiological and pathological processes. CD81 also plays a crucial role in pathogen entry into host cells, including hepatitis C virus (HCV) entry into hepatocytes. HCV is a major cause of liver cirrhosis and hepatocellular carcinoma. HCV entry into hepatocytes is a complex process that requires the coordinated interaction of viral and host factors for the initiation of infection, including CD81, scavenger receptor BI, claudin-1, occludin, membrane-bound host cell kinases, Niemann-Pick C1 Like 1, Harvey rat sarcoma viral oncogene homolog (HRas), CD63 and transferrin receptor 1. Furthermore, recent data in HCV model systems have demonstrated that targeting critical components of tetraspanins and associated cell membrane proteins open new avenues to prevent and treat viral infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据